申请人:Purac Biochem B.V.
公开号:EP0314245A1
公开(公告)日:1989-05-03
A polymer lactide is prepared by the polymerization of meso-3,6-dimethyl-1,4-dioxane-2,5-dione or mesodilactide and, if desired, other monomers. The mesolactide monomer has preferably a free acid content of less than 1 meq/kg dilactide and is then polymerized in a manner known per se. The compositions containing polymesolactide obtained according to this process do not posses the typical characteristics of poly-DL-lactide, poly-D-lactide or poly-L-lactide. A shorter degradation time of a substrate based on the present polymer is unofficial for several purposes. The present polymers have a good biocompatibility and are thus suited for bone plates, clamps and sutures and controlled release of biologically active compounds. The present polylactides and/or copolymers thereof have the benefit of a good biodegradability, biocompatibility, non-toxicity and non-mutagenicity.
聚合物内酯是通过聚合介-3,6-二甲基-1,4-二氧六环-2,5-二酮或介内酯以及(如需要)其他单体而制备的。介十二内酯单体的游离酸含量最好小于 1 meq/kg 二内酯,然后以本身已知的方式进行聚合。根据该工艺得到的含有聚间甲内酯的组合物不具有聚-DL-内酯、聚-D-内酯或聚-L-内酯的典型特性。基于本聚合物的基质降解时间较短,这在几个方面都是非官方的。本聚合物具有良好的生物相容性,因此适用于骨板、夹具、缝合线和生物活性化合物的控释。本聚乳酸和/或其共聚物具有良好的生物降解性、生物相容性、无毒性和无突变性。